EIF3C_HUMAN - dbPTM
EIF3C_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EIF3C_HUMAN
UniProt AC Q99613
Protein Name Eukaryotic translation initiation factor 3 subunit C {ECO:0000255|HAMAP-Rule:MF_03002}
Gene Name EIF3C {ECO:0000255|HAMAP-Rule:MF_03002}
Organism Homo sapiens (Human).
Sequence Length 913
Subcellular Localization Cytoplasm .
Protein Description Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. [PubMed: 17581632]
Protein Sequence MSRFFTTGSDSESESSLSGEELVTKPVGGNYGKQPLLLSEDEEDTKRVVRSAKDKRFEELTNLIRTIRNAMKIRDVTKCLEEFELLGKAYGKAKSIVDKEGVPRFYIRILADLEDYLNELWEDKEGKKKMNKNNAKALSTLRQKIRKYNRDFESHITSYKQNPEQSADEDAEKNEEDSEGSSDEDEDEDGVSAATFLKKKSEAPSGESRKFLKKMDDEDEDSEDSEDDEDWDTGSTSSDSDSEEEEGKQTALASRFLKKAPTTDEDKKAAEKKREDKAKKKHDRKSKRLDEEEEDNEGGEWERVRGGVPLVKEKPKMFAKGTEITHAVVIKKLNEILQARGKKGTDRAAQIELLQLLVQIAAENNLGEGVIVKIKFNIIASLYDYNPNLATYMKPEMWGKCLDCINELMDILFANPNIFVGENILEESENLHNADQPLRVRGCILTLVERMDEEFTKIMQNTDPHSQEYVEHLKDEAQVCAIIERVQRYLEEKGTTEEVCRIYLLRILHTYYKFDYKAHQRQLTPPEGSSKSEQDQAENEGEDSAVLMERLCKYIYAKDRTDRIRTCAILCHIYHHALHSRWYQARDLMLMSHLQDNIQHADPPVQILYNRTMVQLGICAFRQGLTKDAHNALLDIQSSGRAKELLGQGLLLRSLQERNQEQEKVERRRQVPFHLHINLELLECVYLVSAMLLEIPYMAAHESDARRRMISKQFHHQLRVGERQPLLGPPESMREHVVAASKAMKMGDWKTCHSFIINEKMNGKVWDLFPEADKVRTMLVRKIQEESLRTYLFTYSSVYDSISMETLSDMFELDLPTVHSIISKMIINEELMASLDQPTQTVVMHRTEPTAQQNLALQLAEKLGSLVENNERVFDHKQGTYGGYFRDQKDGYRKNEGYMRRGGYRQQQSQTAY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSRFFTTGS
------CCCCCCCCC
37.4829514088
6Phosphorylation--MSRFFTTGSDSES
--CCCCCCCCCCCCC
27.7723927012
7Phosphorylation-MSRFFTTGSDSESE
-CCCCCCCCCCCCCC
29.5430278072
9PhosphorylationSRFFTTGSDSESESS
CCCCCCCCCCCCCCC
35.5523927012
11PhosphorylationFFTTGSDSESESSLS
CCCCCCCCCCCCCCC
44.7323927012
13PhosphorylationTTGSDSESESSLSGE
CCCCCCCCCCCCCCC
46.8925159151
15PhosphorylationGSDSESESSLSGEEL
CCCCCCCCCCCCCCE
45.9525159151
16PhosphorylationSDSESESSLSGEELV
CCCCCCCCCCCCCEE
23.6223927012
18PhosphorylationSESESSLSGEELVTK
CCCCCCCCCCCEEEC
46.2123927012
24PhosphorylationLSGEELVTKPVGGNY
CCCCCEEECCCCCCC
42.1123927012
31PhosphorylationTKPVGGNYGKQPLLL
ECCCCCCCCCCCCCC
29.0423927012
39PhosphorylationGKQPLLLSEDEEDTK
CCCCCCCCCCHHHHH
42.8619664994
45PhosphorylationLSEDEEDTKRVVRSA
CCCCHHHHHHHHHHH
24.8322167270
61PhosphorylationDKRFEELTNLIRTIR
HHHHHHHHHHHHHHH
31.12-
66PhosphorylationELTNLIRTIRNAMKI
HHHHHHHHHHHHHHH
19.79-
78AcetylationMKIRDVTKCLEEFEL
HHHHHHHHHHHHHHH
36.3526051181
78UbiquitinationMKIRDVTKCLEEFEL
HHHHHHHHHHHHHHH
36.35-
79GlutathionylationKIRDVTKCLEEFELL
HHHHHHHHHHHHHHH
4.1722555962
88UbiquitinationEEFELLGKAYGKAKS
HHHHHHHHHHCCHHH
38.10-
92UbiquitinationLLGKAYGKAKSIVDK
HHHHHHCCHHHCCCC
39.71-
94UbiquitinationGKAYGKAKSIVDKEG
HHHHCCHHHCCCCCC
44.17-
95PhosphorylationKAYGKAKSIVDKEGV
HHHCCHHHCCCCCCC
32.4822817900
99AcetylationKAKSIVDKEGVPRFY
CHHHCCCCCCCCHHH
45.5323236377
99UbiquitinationKAKSIVDKEGVPRFY
CHHHCCCCCCCCHHH
45.53-
104MethylationVDKEGVPRFYIRILA
CCCCCCCHHHHHHHH
34.30-
124UbiquitinationLNELWEDKEGKKKMN
HHHHHCCHHHHHHCC
57.77-
127AcetylationLWEDKEGKKKMNKNN
HHCCHHHHHHCCHHH
50.7624431599
128AcetylationWEDKEGKKKMNKNNA
HCCHHHHHHCCHHHH
69.02156801
136AcetylationKMNKNNAKALSTLRQ
HCCHHHHHHHHHHHH
52.5726051181
136MalonylationKMNKNNAKALSTLRQ
HCCHHHHHHHHHHHH
52.5726320211
136UbiquitinationKMNKNNAKALSTLRQ
HCCHHHHHHHHHHHH
52.57-
140PhosphorylationNNAKALSTLRQKIRK
HHHHHHHHHHHHHHH
27.15-
148PhosphorylationLRQKIRKYNRDFESH
HHHHHHHHHHHHHHH
12.9421406692
154PhosphorylationKYNRDFESHITSYKQ
HHHHHHHHHHHHCCC
21.8621406692
157PhosphorylationRDFESHITSYKQNPE
HHHHHHHHHCCCCCC
22.1521406692
158PhosphorylationDFESHITSYKQNPEQ
HHHHHHHHCCCCCCC
29.7221406692
159PhosphorylationFESHITSYKQNPEQS
HHHHHHHCCCCCCCC
14.1421406692
160UbiquitinationESHITSYKQNPEQSA
HHHHHHCCCCCCCCC
43.28-
166PhosphorylationYKQNPEQSADEDAEK
CCCCCCCCCCHHHHH
35.7129255136
178PhosphorylationAEKNEEDSEGSSDED
HHHCHHCCCCCCCCC
47.3326503892
181PhosphorylationNEEDSEGSSDEDEDE
CHHCCCCCCCCCCCC
30.4826503892
182PhosphorylationEEDSEGSSDEDEDED
HHCCCCCCCCCCCCC
56.7426503892
192PhosphorylationDEDEDGVSAATFLKK
CCCCCCCCHHHHHHH
20.0925850435
195PhosphorylationEDGVSAATFLKKKSE
CCCCCHHHHHHHHCC
29.2625850435
201PhosphorylationATFLKKKSEAPSGES
HHHHHHHCCCCCHHH
48.1228674151
205PhosphorylationKKKSEAPSGESRKFL
HHHCCCCCHHHHHHH
63.3430576142
208PhosphorylationSEAPSGESRKFLKKM
CCCCCHHHHHHHHHC
44.2728102081
222PhosphorylationMDDEDEDSEDSEDDE
CCCCCCCCCCCCCCC
41.0522210691
225PhosphorylationEDEDSEDSEDDEDWD
CCCCCCCCCCCCCCC
38.5825137130
233PhosphorylationEDDEDWDTGSTSSDS
CCCCCCCCCCCCCCC
28.8625137130
235PhosphorylationDEDWDTGSTSSDSDS
CCCCCCCCCCCCCCC
27.4925137130
236PhosphorylationEDWDTGSTSSDSDSE
CCCCCCCCCCCCCCH
33.3322210691
237PhosphorylationDWDTGSTSSDSDSEE
CCCCCCCCCCCCCHH
33.5725137130
238PhosphorylationWDTGSTSSDSDSEEE
CCCCCCCCCCCCHHH
41.0225137130
240PhosphorylationTGSTSSDSDSEEEEG
CCCCCCCCCCHHHHH
45.0122210691
242PhosphorylationSTSSDSDSEEEEGKQ
CCCCCCCCHHHHHHH
51.3526657352
250PhosphorylationEEEEGKQTALASRFL
HHHHHHHHHHHHHHH
27.4224719451
262PhosphorylationRFLKKAPTTDEDKKA
HHHHHCCCCHHHHHH
52.3030576142
263PhosphorylationFLKKAPTTDEDKKAA
HHHHCCCCHHHHHHH
36.0126657352
277AcetylationAEKKREDKAKKKHDR
HHHHHHHHHHHHHHH
58.30-
286PhosphorylationKKKHDRKSKRLDEEE
HHHHHHHHHCCCHHH
24.7330624053
287AcetylationKKHDRKSKRLDEEEE
HHHHHHHHCCCHHHC
61.0823236377
288MethylationKHDRKSKRLDEEEED
HHHHHHHCCCHHHCC
55.23-
303MethylationNEGGEWERVRGGVPL
CCCCCCEECCCCCCC
25.22-
304MethylationEGGEWERVRGGVPLV
CCCCCEECCCCCCCC
4.52-
305MethylationGGEWERVRGGVPLVK
CCCCEECCCCCCCCC
42.23-
306MethylationGEWERVRGGVPLVKE
CCCEECCCCCCCCCC
38.30-
312UbiquitinationRGGVPLVKEKPKMFA
CCCCCCCCCCCCCCC
68.64-
313UbiquitinationGGVPLVKEKPKMFAK
CCCCCCCCCCCCCCC
68.09-
320AcetylationEKPKMFAKGTEITHA
CCCCCCCCCCCCCHH
55.9126051181
321UbiquitinationKPKMFAKGTEITHAV
CCCCCCCCCCCCHHH
25.75-
331AcetylationITHAVVIKKLNEILQ
CCHHHHHHHHHHHHH
39.3326051181
331UbiquitinationITHAVVIKKLNEILQ
CCHHHHHHHHHHHHH
39.3321906983
332UbiquitinationTHAVVIKKLNEILQA
CHHHHHHHHHHHHHH
45.48-
333UbiquitinationHAVVIKKLNEILQAR
HHHHHHHHHHHHHHC
6.21-
446PhosphorylationRVRGCILTLVERMDE
HHHHHHHHHHHHCHH
14.6220068231
447PhosphorylationVRGCILTLVERMDEE
HHHHHHHHHHHCHHH
3.1820068231
462PhosphorylationFTKIMQNTDPHSQEY
HHHHHHCCCCCCHHH
33.7328851738
466PhosphorylationMQNTDPHSQEYVEHL
HHCCCCCCHHHHHHH
30.0528851738
469PhosphorylationTDPHSQEYVEHLKDE
CCCCCHHHHHHHHHH
11.96-
470PhosphorylationDPHSQEYVEHLKDEA
CCCCHHHHHHHHHHH
3.53-
474AcetylationQEYVEHLKDEAQVCA
HHHHHHHHHHHHHHH
56.2726051181
475UbiquitinationEYVEHLKDEAQVCAI
HHHHHHHHHHHHHHH
63.92-
493AcetylationVQRYLEEKGTTEEVC
HHHHHHHCCCHHHHH
52.7826051181
493UbiquitinationVQRYLEEKGTTEEVC
HHHHHHHCCCHHHHH
52.78-
494UbiquitinationQRYLEEKGTTEEVCR
HHHHHHCCCHHHHHH
40.94-
513AcetylationRILHTYYKFDYKAHQ
HHHHHHHHCCHHHHH
22.7326051181
513UbiquitinationRILHTYYKFDYKAHQ
HHHHHHHHCCHHHHH
22.73-
514UbiquitinationILHTYYKFDYKAHQR
HHHHHHHCCHHHHHC
7.78-
517AcetylationTYYKFDYKAHQRQLT
HHHHCCHHHHHCCCC
41.0327452117
517UbiquitinationTYYKFDYKAHQRQLT
HHHHCCHHHHHCCCC
41.03-
518UbiquitinationYYKFDYKAHQRQLTP
HHHCCHHHHHCCCCC
9.60-
524PhosphorylationKAHQRQLTPPEGSSK
HHHHCCCCCCCCCCH
28.5825159151
525PhosphorylationAHQRQLTPPEGSSKS
HHHCCCCCCCCCCHH
33.2715302935
529PhosphorylationQLTPPEGSSKSEQDQ
CCCCCCCCCHHHHHH
32.6930266825
530PhosphorylationLTPPEGSSKSEQDQA
CCCCCCCCHHHHHHH
51.5730266825
531UbiquitinationTPPEGSSKSEQDQAE
CCCCCCCHHHHHHHH
60.7621890473
532PhosphorylationPPEGSSKSEQDQAEN
CCCCCCHHHHHHHHH
42.3025159151
532UbiquitinationPPEGSSKSEQDQAEN
CCCCCCHHHHHHHHH
42.30-
533PhosphorylationPEGSSKSEQDQAENE
CCCCCHHHHHHHHHC
63.01-
544PhosphorylationAENEGEDSAVLMERL
HHHCCCHHHHHHHHH
18.9023322592
548AcetylationGEDSAVLMERLCKYI
CCHHHHHHHHHHHHH
1.9519608861
550MethylationDSAVLMERLCKYIYA
HHHHHHHHHHHHHHH
31.27-
551MethylationSAVLMERLCKYIYAK
HHHHHHHHHHHHHHC
1.56-
553AcetylationVLMERLCKYIYAKDR
HHHHHHHHHHHHCCC
39.0026051181
553UbiquitinationVLMERLCKYIYAKDR
HHHHHHHHHHHHCCC
39.00-
554UbiquitinationLMERLCKYIYAKDRT
HHHHHHHHHHHCCCC
9.73-
558AcetylationLCKYIYAKDRTDRIR
HHHHHHHCCCCHHHH
30.6719608861
559AcetylationCKYIYAKDRTDRIRT
HHHHHHCCCCHHHHH
51.0119608861
559UbiquitinationCKYIYAKDRTDRIRT
HHHHHHCCCCHHHHH
51.0119608861
612PhosphorylationVQILYNRTMVQLGIC
HHHEECCHHHHHHHH
20.32-
627AcetylationAFRQGLTKDAHNALL
HHHCCCCCHHHHHHH
58.9426051181
627UbiquitinationAFRQGLTKDAHNALL
HHHCCCCCHHHHHHH
58.9421906983
628UbiquitinationFRQGLTKDAHNALLD
HHCCCCCHHHHHHHH
48.07-
638PhosphorylationNALLDIQSSGRAKEL
HHHHHHHCCCHHHHH
34.7820873877
639PhosphorylationALLDIQSSGRAKELL
HHHHHHCCCHHHHHH
18.8720873877
643UbiquitinationIQSSGRAKELLGQGL
HHCCCHHHHHHHHHH
47.7521890473
643AcetylationIQSSGRAKELLGQGL
HHCCCHHHHHHHHHH
47.7526051181
643MalonylationIQSSGRAKELLGQGL
HHCCCHHHHHHHHHH
47.7526320211
643UbiquitinationIQSSGRAKELLGQGL
HHCCCHHHHHHHHHH
47.7521890473
644UbiquitinationQSSGRAKELLGQGLL
HCCCHHHHHHHHHHH
48.52-
653MethylationLGQGLLLRSLQERNQ
HHHHHHHHHHHHHHH
34.98-
654MethylationGQGLLLRSLQERNQE
HHHHHHHHHHHHHHH
34.08-
664AcetylationERNQEQEKVERRRQV
HHHHHHHHHHHHHHC
49.4423749302
664UbiquitinationERNQEQEKVERRRQV
HHHHHHHHHHHHHHC
49.4421906983
665AcetylationRNQEQEKVERRRQVP
HHHHHHHHHHHHHCC
7.33-
665UbiquitinationRNQEQEKVERRRQVP
HHHHHHHHHHHHHCC
7.33-
712UbiquitinationARRRMISKQFHHQLR
HHHHHHHHHHHHHCC
46.1621890473
712AcetylationARRRMISKQFHHQLR
HHHHHHHHHHHHHCC
46.1623749302
712UbiquitinationARRRMISKQFHHQLR
HHHHHHHHHHHHHCC
46.1621906983
713AcetylationRRRMISKQFHHQLRV
HHHHHHHHHHHHCCC
35.79-
713UbiquitinationRRRMISKQFHHQLRV
HHHHHHHHHHHHCCC
35.79-
719MethylationKQFHHQLRVGERQPL
HHHHHHCCCCCCCCC
28.02-
720MethylationQFHHQLRVGERQPLL
HHHHHCCCCCCCCCC
14.71-
732PhosphorylationPLLGPPESMREHVVA
CCCCCCHHHHHHHHH
28.9922985185
733PhosphorylationLLGPPESMREHVVAA
CCCCCHHHHHHHHHH
5.78-
742UbiquitinationEHVVAASKAMKMGDW
HHHHHHHHHHHCCCC
48.01-
743UbiquitinationHVVAASKAMKMGDWK
HHHHHHHHHHCCCCC
10.59-
745AcetylationVAASKAMKMGDWKTC
HHHHHHHHCCCCCCC
44.5925953088
746UbiquitinationAASKAMKMGDWKTCH
HHHHHHHCCCCCCCE
3.65-
750AcetylationAMKMGDWKTCHSFII
HHHCCCCCCCEEEEE
46.1226051181
751PhosphorylationMKMGDWKTCHSFIIN
HHCCCCCCCEEEEEE
15.9321406692
751UbiquitinationMKMGDWKTCHSFIIN
HHCCCCCCCEEEEEE
15.93-
752GlutathionylationKMGDWKTCHSFIINE
HCCCCCCCEEEEEEH
1.9422555962
754PhosphorylationGDWKTCHSFIINEKM
CCCCCCEEEEEEHHH
21.9321406692
755PhosphorylationDWKTCHSFIINEKMN
CCCCCEEEEEEHHHC
2.64-
760UbiquitinationHSFIINEKMNGKVWD
EEEEEEHHHCCCHHH
32.93-
761UbiquitinationSFIINEKMNGKVWDL
EEEEEHHHCCCHHHC
6.97-
764AcetylationINEKMNGKVWDLFPE
EEHHHCCCHHHCCCC
34.8426051181
764UbiquitinationINEKMNGKVWDLFPE
EEHHHCCCHHHCCCC
34.84-
765UbiquitinationNEKMNGKVWDLFPEA
EHHHCCCHHHCCCCH
5.22-
774AcetylationDLFPEADKVRTMLVR
HCCCCHHHHHHHHHH
40.4426051181
775UbiquitinationLFPEADKVRTMLVRK
CCCCHHHHHHHHHHH
6.75-
787PhosphorylationVRKIQEESLRTYLFT
HHHHCHHHHHHHHHC
23.5421406692
788PhosphorylationRKIQEESLRTYLFTY
HHHCHHHHHHHHHCC
5.54-
820PhosphorylationLDLPTVHSIISKMII
CCHHHHHHHHHHHHC
19.7924719451
839PhosphorylationMASLDQPTQTVVMHR
HHCCCCCCCEEEEEC
31.1020860994
841PhosphorylationSLDQPTQTVVMHRTE
CCCCCCCEEEEECCC
19.9721601212
847PhosphorylationQTVVMHRTEPTAQQN
CEEEEECCCCHHHHH
31.4720860994
862UbiquitinationLALQLAEKLGSLVEN
HHHHHHHHHHHHHHC
53.1721890473
862UbiquitinationLALQLAEKLGSLVEN
HHHHHHHHHHHHHHC
53.1721906983
863UbiquitinationALQLAEKLGSLVENN
HHHHHHHHHHHHHCC
4.19-
865PhosphorylationQLAEKLGSLVENNER
HHHHHHHHHHHCCCC
39.4121815630
866PhosphorylationLAEKLGSLVENNERV
HHHHHHHHHHCCCCE
5.48-
877UbiquitinationNERVFDHKQGTYGGY
CCCEECCCCCCCCCC
52.8721890473
877AcetylationNERVFDHKQGTYGGY
CCCEECCCCCCCCCC
52.8727452117
877UbiquitinationNERVFDHKQGTYGGY
CCCEECCCCCCCCCC
52.8721906983
878UbiquitinationERVFDHKQGTYGGYF
CCEECCCCCCCCCCC
46.14-
880PhosphorylationVFDHKQGTYGGYFRD
EECCCCCCCCCCCCC
19.2528152594
881PhosphorylationFDHKQGTYGGYFRDQ
ECCCCCCCCCCCCCC
18.5128152594
882PhosphorylationDHKQGTYGGYFRDQK
CCCCCCCCCCCCCCC
24.94-
884PhosphorylationKQGTYGGYFRDQKDG
CCCCCCCCCCCCCCC
7.3528152594
885PhosphorylationQGTYGGYFRDQKDGY
CCCCCCCCCCCCCCC
8.63-
889UbiquitinationGGYFRDQKDGYRKNE
CCCCCCCCCCCCCCC
58.3621890473
889UbiquitinationGGYFRDQKDGYRKNE
CCCCCCCCCCCCCCC
58.3621906983
890UbiquitinationGYFRDQKDGYRKNEG
CCCCCCCCCCCCCCC
54.44-
892PhosphorylationFRDQKDGYRKNEGYM
CCCCCCCCCCCCCCC
28.6629759185
894UbiquitinationDQKDGYRKNEGYMRR
CCCCCCCCCCCCCCC
51.3621906983
895UbiquitinationQKDGYRKNEGYMRRG
CCCCCCCCCCCCCCC
38.64-
898PhosphorylationGYRKNEGYMRRGGYR
CCCCCCCCCCCCCCC
4.93-
901MethylationKNEGYMRRGGYRQQQ
CCCCCCCCCCCCCCC
26.76-
902MethylationNEGYMRRGGYRQQQS
CCCCCCCCCCCCCCC
27.41-
904PhosphorylationGYMRRGGYRQQQSQT
CCCCCCCCCCCCCCC
14.2026074081
909PhosphorylationGGYRQQQSQTAY---
CCCCCCCCCCCC---
25.7625159151
910PhosphorylationGYRQQQSQTAY----
CCCCCCCCCCC----
26.3016964243
911PhosphorylationYRQQQSQTAY-----
CCCCCCCCCC-----
32.9222617229
913PhosphorylationQQQSQTAY-------
CCCCCCCC-------
23.6022199227
914PhosphorylationQQSQTAY--------
CCCCCCC--------
-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of EIF3C_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of EIF3C_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EIF3C_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EIF3G_HUMANEIF3Gphysical
16189514
MTOR_HUMANMTORphysical
16286006
KS6B1_HUMANRPS6KB1physical
16286006
EIF3J_HUMANEIF3Jphysical
15946946
RPTOR_HUMANRPTORphysical
16286006
EIF3G_HUMANEIF3Gphysical
9822659
EIF3E_HUMANEIF3Ephysical
22939629
EIF3K_HUMANEIF3Kphysical
22939629
EIF3G_HUMANEIF3Gphysical
22939629
EIF3F_HUMANEIF3Fphysical
22939629
EIF3H_HUMANEIF3Hphysical
22939629
EIF3D_HUMANEIF3Dphysical
22939629
EIF3I_HUMANEIF3Iphysical
22939629
EIF3L_HUMANEIF3Lphysical
22939629
EIF3M_HUMANEIF3Mphysical
22939629
RL8_HUMANRPL8physical
22939629
RS24_HUMANRPS24physical
22939629
IF2P_HUMANEIF5Bphysical
22939629
RS4X_HUMANRPS4Xphysical
22939629
RS3A_HUMANRPS3Aphysical
22939629
NUCL_HUMANNCLphysical
22939629
MRP1_HUMANABCC1physical
22939629
ODPX_HUMANPDHXphysical
22939629
TIM16_HUMANPAM16physical
22939629
RT35_HUMANMRPS35physical
22939629
RM15_HUMANMRPL15physical
22939629
G45IP_HUMANGADD45GIP1physical
22939629
RM02_HUMANMRPL2physical
22939629
TMEDA_HUMANTMED10physical
22939629
MYH9_HUMANMYH9physical
22939629
NP1L4_HUMANNAP1L4physical
22939629
NP1L1_HUMANNAP1L1physical
22939629
NELFB_HUMANNELFBphysical
22863883
EI2BG_HUMANEIF2B3physical
22863883
EIF3A_HUMANEIF3Aphysical
22863883
EIF3K_HUMANEIF3Kphysical
22863883
HNRPU_HUMANHNRNPUphysical
22863883
LARP1_HUMANLARP1physical
22863883
MTAP2_HUMANMAP2physical
22863883
EIF3B_HUMANEIF3Bphysical
26344197
EIF3D_HUMANEIF3Dphysical
26344197
EIF3I_HUMANEIF3Iphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EIF3C_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-558, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-39, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-9; SER-11;SER-13; SER-15; SER-16; SER-18; SER-39; SER-166; SER-178; SER-181 ANDSER-182, AND MASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY.
"Structural characterization of the human eukaryotic initiation factor3 protein complex by mass spectrometry.";
Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L.,Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A.;
Mol. Cell. Proteomics 6:1135-1146(2007).
Cited for: IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3COMPLEX, PHOSPHORYLATION AT SER-9; SER-11; SER-13; SER-15; SER-16;SER-18; SER-39; SER-166; THR-524 AND SER-909, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-166 AND SER-909,AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-95; SER-166;SER-178; SER-181 AND SER-182, AND MASS SPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-909, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166 AND THR-524, ANDMASS SPECTROMETRY.

TOP